Vantis Vascular, a San Jose, California-based privately held medical technology company developing performance-driven technologies for coronary interventions, has received the U.S. Food and Drug Administration (FDA) 510(k) clearance for a new 6 French (6F) model of its CrossFAST Integrated Microcatheter Advanced Delivery System.